Every issue of The Renewal, in one place.
Eight patients received brain transplants of lab-grown dopamine cells. A year later, here's exactly what the peer-reviewed data shows, and what it doesn't.
Jul 30, 2026
•
4 min read
A Boston biotech just dosed the first human with a therapy meant to reset a cell's biological age. Here's what was actually shown, and what wasn't.
Jul 23, 2026
5 min read
The FDA just expanded a landmark gene therapy to children as young as 2. Here's what Casgevy actually does, and why the age expansion matters.
Jul 12, 2026
The first person to receive stem cell therapy for Huntington's disease was treated last month. Here is exactly what we know, and what we don't.
Jul 3, 2026
A 12-person Chicago trial just put every participant off insulin. What that result means, what it doesn't, and why it matters to stem cell therapy.
Jun 19, 2026
